| Literature DB >> 35652333 |
Alisa S Wolberg1, Yaqiu Sang1.
Abstract
As the third most common vascular disease, venous thromboembolism is associated with significant mortality and morbidity. Pathogenesis underlying venous thrombosis is still not fully understood. Accumulating data suggest fibrin network structure and factor XIII-mediated crosslinking are major determinants of venous thrombus mass, composition, and stability. Understanding the cellular and molecular mechanisms mediating fibrin(ogen) and factor XIII production and function and their ability to influence venous thrombosis and resolution may inspire new anticoagulant strategies that target these proteins to reduce or prevent venous thrombosis in certain at-risk patients. This article summarizes fibrinogen and factor XIII biology and current knowledge of their function during venous thromboembolism.Entities:
Keywords: anticoagulant; fibrinogen; hemostasis; red blood cell; venous thrombosis
Mesh:
Substances:
Year: 2022 PMID: 35652333 PMCID: PMC9339521 DOI: 10.1161/ATVBAHA.122.317164
Source DB: PubMed Journal: Arterioscler Thromb Vasc Biol ISSN: 1079-5642 Impact factor: 10.514